510(k) Report

PMA · Approved

Approved

Eluvia Drug-Eluting Vascular Stent System

P180011PMAApproved Sep 18, 2018158-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific Corp · NIU Stent, Superficial Femoral Artery, Drug-Eluting

Approved on Sep 18, 2018 through premarket approval, which rests on the device’s own clinical evidence after a 158-day review.

Decided
Sep 18, 2018
Review
158 days
Class
Class III
Product code
NIU
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P180011 has 67 supplements since 2018: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2018: 32019: 172020: 192021: 82022: 32023: 52024: 62025: 32026: 3
2018high 19 (2020) · low 3 (2018)2026
View FIG. 1 as a table
YearSupplements approved
20183
201917
202019
20218
20223
20235
20246
20253
20263
FIG. 1 — Supplements to P180011, 2018–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NIU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All NIU devices

NIU Stent, Superficial Femoral Artery, Drug-Eluting: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · NIU

4in 2025

2012: 12013: 82015: 62016: 52017: 42018: 102019: 202020: 222021: 92022: 52023: 72024: 72025: 42026 (partial year): 4
2007high 22 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NIU

Too few NIU 510(k)s in any year since 2007 to give a median.

Recalls per year · NIU

No recall names NIU since 2007.

Adverse event reports per year · NIU

181in 2025

2013: 202014: 1692015: 1682016: 2322017: 2792018: 1942019: 2952020: 3192021: 2252022: 2542023: 2482024: 1752025: 181
2007high 319 (2020) · low 0 (2007)2025

MAUDE reports naming product code NIU, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20121—00
20138—020
20140—0169
20156—0168
20165—0232
20174—0279
201810—0194
201920—0295
202022—0319
20219—0225
20225—0254
20237—0248
20247—0175
20254—0181
20264—0—
Cite this page

510(k) Report. “P180011: Eluvia Drug-Eluting Vascular Stent System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P180011

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026